- Report
- April 2025
- 181 Pages
Global
From €3967EUR$4,500USD£3,460GBP
- Report
- April 2025
- 187 Pages
Global
From €3967EUR$4,500USD£3,460GBP
- Report
- March 2025
- 185 Pages
Global
From €3967EUR$4,500USD£3,460GBP
- Report
- February 2025
- 182 Pages
Global
From €3967EUR$4,500USD£3,460GBP
- Report
- February 2025
- 182 Pages
Global
From €3967EUR$4,500USD£3,460GBP
- Report
- November 2025
- 200 Pages
Global
From €5607EUR$6,360USD£4,890GBP
€7009EUR$7,950USD£6,112GBP
- Report
- November 2025
- 200 Pages
Global
From €7009EUR$7,950USD£6,112GBP
- Report
- November 2025
- 200 Pages
Global
From €5607EUR$6,360USD£4,890GBP
€7009EUR$7,950USD£6,112GBP
- Report
- November 2025
- 200 Pages
Global
From €5607EUR$6,360USD£4,890GBP
€7009EUR$7,950USD£6,112GBP
- Drug Pipelines
- June 2025
- 150 Pages
Global
From €2645EUR$3,000USD£2,307GBP
€3306EUR$3,750USD£2,883GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €2116EUR$2,400USD£1,845GBP
€2645EUR$3,000USD£2,307GBP
- Drug Pipelines
- April 2025
- 450 Pages
Global
From €3527EUR$4,000USD£3,075GBP
€4408EUR$5,000USD£3,844GBP
- Clinical Trials
- April 2025
- 550 Pages
Global
From €3527EUR$4,000USD£3,075GBP
€4408EUR$5,000USD£3,844GBP
- Clinical Trials
- April 2025
- 280 Pages
Global
From €2116EUR$2,400USD£1,845GBP
€2645EUR$3,000USD£2,307GBP
- Drug Pipelines
- April 2025
- 280 Pages
Global
From €2116EUR$2,400USD£1,845GBP
€2645EUR$3,000USD£2,307GBP
- Clinical Trials
- April 2025
- 450 Pages
Global
From €3527EUR$4,000USD£3,075GBP
€4408EUR$5,000USD£3,844GBP
- Drug Pipelines
- April 2025
- 200 Pages
Global
From €1763EUR$2,000USD£1,538GBP
€2204EUR$2,500USD£1,922GBP
- Clinical Trials
- April 2025
- 180 Pages
Global
From €1763EUR$2,000USD£1,538GBP
€2204EUR$2,500USD£1,922GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1411EUR$1,600USD£1,230GBP
€1763EUR$2,000USD£1,538GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1058EUR$1,200USD£923GBP
€1322EUR$1,500USD£1,153GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more